Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

166 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Ligands regulate cell surface level of the human kappa opioid receptor by activation-induced down-regulation and pharmacological chaperone-mediated enhancement: differential effects of nonpeptide and peptide agonists.
Chen Y, Chen C, Wang Y, Liu-Chen LY. Chen Y, et al. J Pharmacol Exp Ther. 2006 Nov;319(2):765-75. doi: 10.1124/jpet.106.107987. Epub 2006 Aug 1. J Pharmacol Exp Ther. 2006. PMID: 16882876
Ezrin-radixin-moesin-binding phosphoprotein-50/Na+/H+ exchanger regulatory factor (EBP50/NHERF) blocks U50,488H-induced down-regulation of the human kappa opioid receptor by enhancing its recycling rate.
Li JG, Chen C, Liu-Chen LY. Li JG, et al. J Biol Chem. 2002 Jul 26;277(30):27545-52. doi: 10.1074/jbc.M200058200. Epub 2002 May 9. J Biol Chem. 2002. PMID: 12004055
(-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: structural basis for the differential regulation.
Zhang F, Li J, Li JG, Liu-Chen LY. Zhang F, et al. J Pharmacol Exp Ther. 2002 Sep;302(3):1184-92. doi: 10.1124/jpet.302.3.1184. J Pharmacol Exp Ther. 2002. PMID: 12183679
Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
Li JG, Zhang F, Jin XL, Liu-Chen LY. Li JG, et al. J Pharmacol Exp Ther. 2003 May;305(2):531-40. doi: 10.1124/jpet.102.045559. Epub 2003 Jan 24. J Pharmacol Exp Ther. 2003. PMID: 12606694
Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization.
Szabo I, Wetzel MA, Zhang N, Steele AD, Kaminsky DE, Chen C, Liu-Chen LY, Bednar F, Henderson EE, Howard OM, Oppenheim JJ, Rogers TJ. Szabo I, et al. J Leukoc Biol. 2003 Dec;74(6):1074-82. doi: 10.1189/jlb.0203067. Epub 2003 Sep 12. J Leukoc Biol. 2003. PMID: 12972507
Differential effects of agonists on adenylyl cyclase superactivation mediated by the kappa opioid receptors: adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization, and down-regulation.
Wang Y, Li JG, Huang P, Xu W, Liu-Chen LY. Wang Y, et al. J Pharmacol Exp Ther. 2003 Dec;307(3):1127-34. doi: 10.1124/jpet.103.055814. Epub 2003 Oct 13. J Pharmacol Exp Ther. 2003. PMID: 14557376
Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor.
Chen C, Li J, Bot G, Szabo I, Rogers TJ, Liu-Chen LY. Chen C, et al. Eur J Pharmacol. 2004 Jan 12;483(2-3):175-86. doi: 10.1016/j.ejphar.2003.10.033. Eur J Pharmacol. 2004. PMID: 14729105
kappa Opioid receptor interacts with Na(+)/H(+)-exchanger regulatory factor-1/Ezrin-radixin-moesin-binding phosphoprotein-50 (NHERF-1/EBP50) to stimulate Na(+)/H(+) exchange independent of G(i)/G(o) proteins.
Huang P, Steplock D, Weinman EJ, Hall RA, Ding Z, Li J, Wang Y, Liu-Chen LY. Huang P, et al. J Biol Chem. 2004 Jun 11;279(24):25002-9. doi: 10.1074/jbc.M313366200. Epub 2004 Apr 7. J Biol Chem. 2004. PMID: 15070904
166 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback